• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蓝斑核神经保护药物文迪苯醇可使阿尔茨海默病 5xFAD 转基因小鼠模型的行为正常化。

The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.

机构信息

Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, United States.

Department of Anesthesiology, University of Illinois, Chicago, IL 60614, United States; Jesse Brown VA Medical Center, Chicago, IL 60614, United States.

出版信息

Brain Res. 2019 Jan 1;1702:29-37. doi: 10.1016/j.brainres.2017.12.028. Epub 2017 Dec 21.

DOI:10.1016/j.brainres.2017.12.028
PMID:29274883
Abstract

Damage to noradrenergic neurons in the Locus coeruleus (LC) occurs contributes to neuropathology and behavioral deficits in Alzheimer's disease (AD); methods to reduce LC damage may therefore be of benefit. We previously showed that vindeburnol, a derivative of the plant alkaloid vincamine, reduced neuroinflammation, amyloid burden, and LC damage in a mouse model of AD; however, effects on behavior were not tested. We now tested the effects of vindeburnol on anxiety-like behavior in 5xFAD mice which develop robust amyloid burden at early ages. During novel object recognition testing, we observed that 5xFAD mice spent more time exploring than wildtype littermates, and that time was reduced by vindeburnol. Vindeburnol also reduced hyperlocomotion in the 5xFAD mice which may have contributed to their increased exploration times. In an open field test, vindeburnol normalized the increase of time spent in the center, and the decrease of time spent near the walls in 5xFAD mice. Vindeburnol reduced amyloid burden in the hippocampus and cortex, areas that contribute to regulation of anxiety-like behavior. In vitro, vindeburnol increased neuronal BDNF expression in a cAMP-dependent manner; and inhibited phosphodiesterase activity with an EC near 50 μM. These findings suggest that cAMP-mediated increases in neurotrophic factors contribute to beneficial effects of vindeburnol within the context of LC damage, which may be of value for treatment of some neuropsychiatric symptoms of AD.

摘要

蓝斑(LC)去甲肾上腺素能神经元损伤导致阿尔茨海默病(AD)的神经病理学和行为缺陷;因此,减少 LC 损伤的方法可能是有益的。我们之前曾表明,vin-deburnol 是 vincamine 植物生物碱的衍生物,可减少 AD 小鼠模型中的神经炎症、淀粉样蛋白负担和 LC 损伤;然而,尚未测试其对行为的影响。我们现在测试了 vindeburnol 对 5xFAD 小鼠焦虑样行为的影响,5xFAD 小鼠在早期就会出现明显的淀粉样蛋白负担。在新物体识别测试中,我们观察到 5xFAD 小鼠比野生型同窝仔鼠花费更多的时间探索,而 vindeburnol 减少了它们的探索时间。Vindeburnol 还减少了 5xFAD 小鼠的过度活动,这可能导致它们的探索时间增加。在开放场测试中,vindeburnol 使 5xFAD 小鼠在中央区域花费的时间增加和靠近墙壁区域花费的时间减少恢复正常。Vindeburnol 减少了海马体和皮质中的淀粉样蛋白负担,这些区域有助于调节焦虑样行为。体外实验中,vindeburnol 以 cAMP 依赖的方式增加神经元 BDNF 表达;并以接近 50 μM 的 EC 抑制磷酸二酯酶活性。这些发现表明,cAMP 介导的神经营养因子增加可能有助于 vindeburnol 在 LC 损伤背景下的有益作用,这对于治疗 AD 的某些神经精神症状可能具有价值。

相似文献

1
The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.蓝斑核神经保护药物文迪苯醇可使阿尔茨海默病 5xFAD 转基因小鼠模型的行为正常化。
Brain Res. 2019 Jan 1;1702:29-37. doi: 10.1016/j.brainres.2017.12.028. Epub 2017 Dec 21.
2
The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.文拉法辛衍生物文拉布醇在多发性硬化症的小鼠模型中提供益处:对蓝斑的影响。
J Neurochem. 2012 Apr;121(2):206-16. doi: 10.1111/j.1471-4159.2012.07673.x. Epub 2012 Feb 17.
3
Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.海马脑源性神经营养因子的条件性缺失加剧了阿尔茨海默病小鼠模型的神经病理学变化。
ASN Neuro. 2017 Mar-Apr;9(2):1759091417696161. doi: 10.1177/1759091417696161.
4
Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.蓝斑核消融加剧 P301S tau 转基因小鼠的认知缺陷、神经病理学和致死性。
J Neurosci. 2018 Jan 3;38(1):74-92. doi: 10.1523/JNEUROSCI.1483-17.2017. Epub 2017 Nov 13.
5
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.去甲肾上腺素前体 L-DOPS 可减少阿尔茨海默病小鼠模型中的病变。
Neurobiol Aging. 2012 Aug;33(8):1651-63. doi: 10.1016/j.neurobiolaging.2011.04.012. Epub 2011 Jun 25.
6
Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.淀粉样-β淀粉样变性 APP 敲入小鼠模型中蓝斑去甲肾上腺素能纤维密度普遍降低。
J Alzheimers Dis. 2021;82(4):1513-1530. doi: 10.3233/JAD-210385.
7
Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.通过蓝斑核介导的神经炎症的原因、后果及治疗方法:去甲肾上腺素能信号系统
J Neurochem. 2016 Oct;139 Suppl 2:154-178. doi: 10.1111/jnc.13447. Epub 2016 Mar 10.
8
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.大脑中去甲肾上腺素缺乏会增加阿尔茨海默病动物模型中的β-淀粉样蛋白斑块负担。
Neurobiol Aging. 2007 Aug;28(8):1206-14. doi: 10.1016/j.neurobiolaging.2006.06.003. Epub 2006 Jul 11.
9
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.蓝斑核变性促进淀粉样前体蛋白23转基因小鼠的阿尔茨海默病发病机制。
J Neurosci. 2006 Feb 1;26(5):1343-54. doi: 10.1523/JNEUROSCI.4236-05.2006.
10
Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.使用一种偏向性和选择性的β1 肾上腺素能受体部分激动剂调节阿尔茨海默病 5XFAD 小鼠模型中的神经炎症和病理。
Neuropharmacology. 2017 Apr;116:371-386. doi: 10.1016/j.neuropharm.2017.01.010. Epub 2017 Jan 13.

引用本文的文献

1
Qifuyin alleviates anxiety and depression in 3×Tg-AD mice by modulating neuroendocrine function.芪附饮通过调节神经内分泌功能减轻3×Tg-AD小鼠的焦虑和抑郁。
Front Psychiatry. 2025 May 14;16:1554866. doi: 10.3389/fpsyt.2025.1554866. eCollection 2025.
2
Regenerating Locus Coeruleus-Norepinephrine (LC-NE) Function: A Novel Approach for Neurodegenerative Diseases.恢复蓝斑-去甲肾上腺素(LC-NE)功能:一种治疗神经退行性疾病的新方法。
Cell Prolif. 2025 Jun;58(6):e13807. doi: 10.1111/cpr.13807. Epub 2025 Jan 28.
3
Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity.
HSV-1 中枢神经系统感染的嗅觉和三叉神经途径与局部小胶质细胞异质性。
J Virol. 2024 Nov 19;98(11):e0096824. doi: 10.1128/jvi.00968-24. Epub 2024 Oct 30.
4
Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms.阿尔茨海默病中的单胺变化及其在共病神经精神症状中的意义。
Geroscience. 2025 Feb;47(1):457-482. doi: 10.1007/s11357-024-01359-x. Epub 2024 Sep 27.
5
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer's disease.p85S6K 维持突触 GluA1 以改善阿尔茨海默病的认知缺陷。
Transl Neurodegener. 2023 Jan 9;12(1):1. doi: 10.1186/s40035-022-00334-w.
6
Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target.阿尔茨海默病中的去甲肾上腺素:一个新的潜在治疗靶点。
Int J Mol Sci. 2022 May 30;23(11):6143. doi: 10.3390/ijms23116143.
7
Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease.蓝斑核完整性与阿尔茨海默病 Braak 分期及神经精神症状严重程度的相关性。
Neuropsychopharmacology. 2022 Apr;47(5):1128-1136. doi: 10.1038/s41386-022-01293-6. Epub 2022 Feb 17.
8
Patterns of cognitive decline and somatosensory processing in a mouse model of amyloid accumulation.淀粉样蛋白积累小鼠模型中的认知衰退模式和体感处理
Neurobiol Pain. 2021 Nov 7;10:100076. doi: 10.1016/j.ynpai.2021.100076. eCollection 2021 Aug-Dec.
9
Anxiety and Alzheimer's disease: Behavioral analysis and neural basis in rodent models of Alzheimer's-related neuropathology.焦虑与阿尔茨海默病:阿尔茨海默病相关神经病理学啮齿动物模型中的行为分析和神经基础。
Neurosci Biobehav Rev. 2021 Aug;127:647-658. doi: 10.1016/j.neubiorev.2021.05.005. Epub 2021 May 9.
10
Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.在阿尔茨海默病前驱期,TgF344-AD 大鼠模型中海马β-肾上腺素能受体功能增强可促进突触强化,并支持学习和记忆。
J Neurosci. 2021 Jun 30;41(26):5747-5761. doi: 10.1523/JNEUROSCI.0119-21.2021. Epub 2021 May 5.